Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease

BackgroundTo better understand the patient's heterogeneity in fatty liver disease (FLD), metabolic dysfunction–associated fatty liver disease (MAFLD) was proposed by international experts as a new nomenclature for nonalcoholic fatty liver disease (NAFLD). We aimed to evaluate the cardiovascular...

Full description

Bibliographic Details
Main Authors: Carolina M. Perdomo, Jorge M. Núñez-Córdoba, Ana Ezponda, Francisco J. Mendoza, Javier Ampuero, Gorka Bastarrika, Gema Frühbeck, Javier Escalada
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.1023583/full